LASEA caps moll 80 mg 28 pce
7680630190017
CH-63019
N05BX05
01.04.1.
1 / 3
google
Details
- Product number
- 6301901
- CPT
- -
- Packaging group
- 28
- Unit
- Kapsel(n)
- Composition
- lavandulae aetheroleum (Lavandula angustifolia Mill., aetheroleum) 80 mg, rapae oleum raffinatum, Kapselhülle: glycerolum (85 per centum), succinogelatina, sorbitolum 12.2317 mg, pro capsula.
Articles (1)
Lasea, Kapseln
Kapseln
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
12.2317 MG | Substance | HNIDK |
Authorization holder
Schwabe Pharma AG
6403 Küssnacht am Rigi
Authorization information
- Swissmedic authorization number
- 63019
- Drug name
- Lasea, Kapseln
- Galenic form
- KAPWE
- ATC Code
- N05BX05
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 20/05/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 01.04.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LASEA caps moll 80 mg 28 pce
- Description (DE)
- LASEA Weichkaps 80 mg 28 Stk
- Market launch
- 20/05/2016
- Narcotic (BTM)
- No